• 80% in Every Community is an American Cancer Society National Colorectal Cancer Roundtable campaign to substantially reduce colorectal cancer as a major public health problem.
• Numerous, multi-sectored organizations are working toward the shared goal of reaching colorectal cancer screening rates of 80% and higher in communities across the nation.
• Through dedication, determination, and collective action, we are seeing that 80% and higher screening rates are possible as health systems, community health centers, health plans, employers, counties, and many others are achieving their goals.
• But not everyone is benefiting equally. There are still too many communities with lower colorectal cancer screening rates – certain racial and ethnic communities, communities with lower levels of income and education, and uninsured persons, among others.
• Everyone deserves to live a life free from colorectal cancer. Increasing colorectal cancer screening is only one element of the work that needs to be done to address colorectal cancer disparities. The 80% in Every Community campaign emphasizes that we cannot be satisfied with just reaching a national or even state-level screening rate of 80%; we need to ensure every community can reach the target of 80% and higher.
• Efforts must address disparities along the entire cancer care continuum, including lifestyle risk factors, timely diagnosis following a positive (abnormal) non-colonoscopy screening test result, and timely treatment. Thus, while the 80% in Every Community campaign focuses on increasing colorectal cancer screening participation, it tackles only one piece of the complex puzzle to eliminate disparities in colorectal cancer.

• In 2025, there will be an estimated 154,270 new cases of colorectal cancer diagnosed in the US and 52,900 people will die from the disease.
• Colorectal cancer is the second-leading cause of cancer death in the US when men and women are combined, yet it can often be detected early or prevented through screening.
• 1 in 24 men and 1 in 26 women will be diagnosed with colorectal cancer in their lifetime.

Colorectal cancer screening can save lives, but only if people get tested.

• Screening can prevent colorectal cancer through the detection and removal of precancerous growths (polyps), and it can often detect cancer at an early stage, when treatment is usually more successful.
• Nearly all major guidelines recommend screening for average risk individuals start at age 45 and continue through at least age 75. Previously, major guidelines recommended screening for average risk individuals start at age 50.
• Screening works; an analysis of cancer deaths averted from prevention, screening, and treatment efforts between 1975 and 2000 estimates that during this time frame, CRC deaths were averted because of screening and removal or precancerous polyps or early detection in 79% of cases.
• Yet screening is underutilized; as of 2023, only 65% of adults aged 45 years and older were up to date with screenings.
• In the U.S., screening is lowest among ages 45-49 (37%) and ages 50-54 (55%); Hispanic (56%); Asian Americans (58%); American Indian or Native Alaskan (59%); individuals with less than a high school education (51%), individuals with a lower income (<100% Federal Poverty Level) (51%); the uninsured (25%); and recent (<10 years) immigrants (43%).
• Even if someone feels just fine, following screening recommendations is important.
  • Early stages of colorectal cancer don’t usually cause symptoms, so proactive screening is one of the only ways to detect these types of cancers.
  • Most colorectal cancers occur in people with no family history.
  • Colorectal cancer risk is higher if someone has a close relative who has had the disease.

There are several tests to screen for colorectal cancer.

• Approved tests include: colonoscopy, stool tests like guaiac fecal occult blood test [FOBT], fecal immunochemical test [FIT], mt-sDNA, CT colonoscopy (sometimes called a virtual colonoscopy), and sigmoidoscopy.
• The best test is the test that gets done.
• Most health insurance plans, including Medicare, cover most of these screening tests. Talk with your clinician about which screening tests might be right for you.

Colorectal cancer is swiftly shifting to more advanced disease and younger individuals.

• The proportion of individuals in the United States diagnosed with advanced-stage colorectal cancer increased from 52% in the mid-2000s to 60% in 2019.
• Early age onset colorectal cancer is on the rise. Diagnoses of people under 55 years of age doubled from 11% (1 in 10) in 1995 to 20% (1 in 5) in 2019.
• Colorectal cancer is now the leading cause of cancer death in men and the second in women under 50 years old.

It’s more important than ever that we ensure everyone make a plan for getting regular, potentially life-saving screening as soon as they become eligible—at 45 for people at average risk or earlier for people at increased or high risk of the disease. People of any age with symptoms should undergo an appropriate diagnostic workup.

• 80% in Every Community builds on the work of the ACS NCCRT’s first campaign to reach 80%: 80% by 2018.
• Our shared efforts are working. Health systems, community health centers, health plans, employers, counties, and others are achieving colorectal cancer screening rates of 80% and higher.
• The collective action and collaborative efforts of the ACS NCCRT’s campaigns to reach 80%, starting with 80% by 2018, have achieved tremendous success. Between 2012 and 2018, 9.3 million additional US adults (50 to 75) were screened.
• The ACS NCCRT is tracking all major measures to assess our progress in reaching the goal of 80% of age-eligible adults screened for colorectal cancer.  Visit the Data & Progress webpage to see national progress across key colorectal cancer screening data sets.

• We’ve learned many lessons since we launched our original goal to reach 80%. The most important is that a commitment to partnership, collective action, and the pooling of resources has the potential to save many lives.
• We share a commitment to eliminating disparities in access to care. ACS NCCRT member organizations are working toward a common goal to empower communities, patients, community health centers, health systems, health plans, and others, to close the screening gap.
• 80% in Every Community aims to unite partners to eliminate barriers to screening, because everyone deserves to live a life free from colorectal cancer.

What is an 80% Community?

• The “community” in 80% in Every Community is intended to be flexible and inclusive.
• Communities can be locations, such as a city, county, or state; a racial and ethnic community, a patient population served by a healthcare system, a workforce; or another variation of “community” specific to your needs and priorities.
• Communities are the collective efforts of those stakeholders working together in new ways to increase colorectal cancer screening.
• Addressing the burden of colorectal cancer is most effective as coordinated and collaborative action from multiple actors within the community.

• Commit to the goal. Make a commitment as an organization to work toward our shared goal to reach an 80% screening rate nationwide by placing a focus on increasing the number of people screened for colorectal cancer in communities you serve.
• Spread the word. Many patients and clinicians either don’t know or consider all the options for colorectal cancer Your voice can help connect them to a testing option that is right for them. Visit the NCCRT Resource Center to find resources and tools to support your work.
• Join the conversation: Keep us informed of your community’s success and conversations by using #80inEveryCommunity on social media.
  • NCCRT Twitter
  • NCCRT LinkedIn
  • NCCRT YouTube

1. Cancer Facts & Figures. American Cancer Society. 2025. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf
2. Cancer Prevention & Early Detection Facts & Figures, 2025-2026. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-prevention-and-early-detection-facts-and-figures/2025-cped-files/cped-cff-2025-2026.pdf 
3. Goddard KAB, Feuer EJ, Mandelblatt JS, et al. Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. JAMA Oncol. 2025;11(2):162-167. doi:10.1001/jamaoncol.2024.5381  
4. Colorectal Cancer Facts & Figures. American Cancer Society. 2023-2025. https://www.cancer.org/research/cancer-facts-statistics/colorectal-cancer-facts-figures.html
5. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [2012, 2014, 2016, 2018, 2020].
6. Siegel, R.L., et al. (2023). Colorectal Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21772
7. Rahib, Lola, et. al. (2021) Estimated Projection of US Cancer Incidence and Death to 2040. Jama Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullart